Clinical Study
Transcatheter Mitral Valve Repair in Surgical High-Risk Patients: Gender-Specific Acute and Long-Term Outcomes
Table 5
Univariate cox regression analysis for future death.
| Variable | Men HR (95% CI) | value | Women HR (95% CI) | value |
| Age | 1.02 (1.00–1.04) | 0.0222 | 1.01 (0.99–1.04) | 0.28 | Body mass index | 0.95 (0.91–1.00) | 0.0289 | 0.98 (0.93–1.03) | 0.39 | Hypertension | 0.97 (0.68–1.37) | 0.86 | 1.04 (0.63–1.71) | 0.89 | Hypercholesterolemia | 0.62 (0.45–0.85) | 0.0031 | 1.02 (0.65–1.61) | 0.94 | Diabetes mellitus | 1.03 (0.74–1.42) | 0.87 | 1.78 (1.10–2.87) | 0.019 | Nicotine abuse | 1.16 (0.78–1.72) | 0.46 | 2.04 (1.17–3.53) | 0.0115 | Dilative cardiomyopathy | 1.26 (0.88–1.78) | 0.20 | 1.50 (0.94–2.39) | 0.09 | Ischemic cardiomyopathy | 0.84 (0.62–1.15) | 0.29 | 1.46 (0.92–2.34) | 0.11 | Coronary artery disease | 0.66 (0.46–0.93) | 0.0186 | 1.40 (0.90–2.19) | 0.14 | Renal failure | 1.79 (1.27–2.52) | 0.0009 | 1.97 (1.26–3.09) | 0.0029 | Atrial fibrillation | 1.25 (0.89–1.75) | 0.19 | 1.41 (0.87–2.29) | 0.16 | MR severity 4 versus 3 | 1.40 (1.02–1.91) | 0.0355 | 1.23 (0.79–1.91) | 0.36 | LV ejection fraction < 30% | 1.35 (0.97–1.90) | 0.08 | 1.65 (0.94–2.90) | 0.08 | NT-proBNP (log) | 1.43 (1.22–1.68) | <0.0001 | 1.93 (1.48–2.50) | <0.0001 | Success rate | 0.56 (0.35–0.90) | 0.0172 | 0.78 (0.39–1.57) | 0.49 | Logistic EuroSCORE | 1.00 (1.00–1.00) | 0.83 | 1.02 (1.01–1.03) | 0.0004 | Peripheral artery disease | 1.56 (0.97–2.50) | 0.06 | 1.38 (0.67–2.88) | 0.38 |
|
|
LV = left ventricular; MR = mitral regurgitation; NT-proBNP = N-terminal probrain natriuretic peptide; CI = confidence interval; HR = hazard ratio.
|